Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

4(44.4%)

Phase 4

2(22.2%)

Phase 2

2(22.2%)

Phase 3

1(11.1%)

9Total

N/A(4)

Phase 4(2)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07462715Phase 4Not Yet Recruiting

Statins Against Bushfire Smoke

Role: lead

NCT05366153Recruiting

Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer

Role: collaborator

NCT04896021Not ApplicableCompleted

Improved Cardiovascular Disease hEALth Service Delivery in Australia: Cluster Randomised Controlled Trial (IDEAL Study)

Role: lead

NCT02325830Not ApplicableCompleted

Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation

Role: collaborator

NCT02629952Not ApplicableUnknown

Metabolic Benefits of Drinking Blueberry Tea in Type 2 Diabetes

Role: lead

NCT02708875Not ApplicableUnknown

Microvascular Insulin Resistance and Mixed Meal Challenge

Role: lead

NCT02140580Phase 4Unknown

OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

Role: lead

NCT01176344Phase 3Completed

VItamin D Effect on Osteoarthritis Study

Role: lead

NCT01549938Phase 2Completed

Cholecalciferol Intervention to Prevent Respiratory Infections Study

Role: lead

NCT00273260Phase 2Completed

The Effectiveness of Individualised Bone Density Feedback and Osteoporosis Education in Premenopausal Women

Role: lead

All 10 trials loaded